| pubmed-article:17577218 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17577218 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:17577218 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:17577218 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:17577218 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:17577218 | lifeskim:mentions | umls-concept:C0026259 | lld:lifeskim |
| pubmed-article:17577218 | lifeskim:mentions | umls-concept:C0032952 | lld:lifeskim |
| pubmed-article:17577218 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:17577218 | lifeskim:mentions | umls-concept:C1135132 | lld:lifeskim |
| pubmed-article:17577218 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:17577218 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:17577218 | pubmed:dateCreated | 2007-7-26 | lld:pubmed |
| pubmed-article:17577218 | pubmed:abstractText | This randomized, noncomparative, multicenter, clinical trial evaluated ixabepilone or mitoxantrone/prednisone (MP) as second-line chemotherapy for taxane-refractory, hormone-refractory, prostate cancer (HRPC). | lld:pubmed |
| pubmed-article:17577218 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17577218 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577218 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17577218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577218 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17577218 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:17577218 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:17577218 | pubmed:author | pubmed-author:WildingGeorge... | lld:pubmed |
| pubmed-article:17577218 | pubmed:author | pubmed-author:KellyW... | lld:pubmed |
| pubmed-article:17577218 | pubmed:author | pubmed-author:SmallEric JEJ | lld:pubmed |
| pubmed-article:17577218 | pubmed:author | pubmed-author:HussainMaha... | lld:pubmed |
| pubmed-article:17577218 | pubmed:author | pubmed-author:MichaelsonDro... | lld:pubmed |
| pubmed-article:17577218 | pubmed:author | pubmed-author:GrossMitchell... | lld:pubmed |
| pubmed-article:17577218 | pubmed:author | pubmed-author:WeinbergVivia... | lld:pubmed |
| pubmed-article:17577218 | pubmed:author | pubmed-author:RosenbergJona... | lld:pubmed |
| pubmed-article:17577218 | pubmed:author | pubmed-author:HutcheonDougl... | lld:pubmed |
| pubmed-article:17577218 | pubmed:copyrightInfo | (c) 2007 American Cancer Society. | lld:pubmed |
| pubmed-article:17577218 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17577218 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17577218 | pubmed:volume | 110 | lld:pubmed |
| pubmed-article:17577218 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17577218 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17577218 | pubmed:pagination | 556-63 | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:meshHeading | pubmed-meshheading:17577218... | lld:pubmed |
| pubmed-article:17577218 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17577218 | pubmed:articleTitle | Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : randomized phase 2 study of ixabepilone or mitoxantrone and prednisone. | lld:pubmed |
| pubmed-article:17577218 | pubmed:affiliation | Department of Medicine, University of California at San Francisco, Comprehensive Cancer Center, San Francisco, California, USA. jrosenbe@medicine.ucsf.edu | lld:pubmed |
| pubmed-article:17577218 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17577218 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:17577218 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17577218 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17577218 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:17577218 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:17577218 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17577218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17577218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17577218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17577218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17577218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17577218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17577218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17577218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17577218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17577218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17577218 | lld:pubmed |
